Alvernia University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Alvernia University sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials 1 currently recruiting 1 completed upper quartile by trial count

Alvernia University: 5 sponsored US clinical trials, 1 recruiting.

Alvernia University sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Dynamic Knee Valgus, with 1 trials.

Upper-quartile sponsor footprint

Alvernia University sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Alvernia University pipeline

1 recruiting of 5 indexed (20% open); 1 completed (20%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Dynamic Knee Valgus (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Alvernia University: open-pipeline peers nationwide

Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

Alvernia University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4.95.05.055.05.05.1 0%5%10%15%20%25% Total trials Recruiting share Alvernia University4YouandMeAbbott Rapid DxAccess Business GroupAcera SurgicalAlign TechnologyAltruBioAmazentisAnalog Device
Alvernia University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Alvernia University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

What to do with this Alvernia University page

5 registered trials is a research-attention snapshot, not an endorsement of Alvernia University or any single study.

  • 1 of Alvernia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Dynamic Knee Valgus is the condition Alvernia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dynamic Knee Valgus trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Alvernia University pipeline card: 5 registered trials from official public datasets.Report a data error.